Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Life Tech's Ion AmpliSeq Panels

Premium

Life Technologies has launched an Ion AmpliSeq BRCA1 and BRCA2 Panel as well as an Ion AmpliSeq Colon and Lung Cancer Panel.

The BRCA panel analyzes the coding regions of the BRCA1 and BRCA2 genes and was developed by researchers from Radboud University Nijmegen Medical Center and the University of Porto. The lung and colon panel analyzes over 500 mutations in 22 genes and was developed by eight institutions, including Radboud University Nijmegen Medical Center; Cancer Research Center of Mercogliano in Italy; the genetics and molecular biology division of pharmaceutical company Viollier in Switzerland; the University of Warwick in the UK; the Institut Gustave Roussy in France; the University Paris Descartes Center in France; and St James' Hospital in Dublin.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.